{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:53:41Z","timestamp":1760266421606},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1097\/01.coc.0000046301.83671.09","type":"journal-article","created":{"date-parts":[[2004,1,30]],"date-time":"2004-01-30T09:04:36Z","timestamp":1075453476000},"page":"68-72","source":"Crossref","is-referenced-by-count":26,"title":["Multimodality Therapy for Thymic Carcinoma (TCA)"],"prefix":"10.1097","volume":"27","author":[{"given":"Francisco J.","family":"Hernandez-Ilizaliturri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cipolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Debb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nithya","family":"Ramnath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210128","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1097-0142(19860801)58:3<765::AID-CNCR2820580326>3.0.CO;2-S","article-title":"Thymomas: A review of 169 cases, with particular reference to results of surgical treatment","volume":"58","author":"Maggi","year":"1986","journal-title":"Cancer"},{"key":"R2-12-20210128","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00000478-198207000-00007","article-title":"Thymic carcinoma: Five distinctive histological variants","volume":"6","author":"Snover","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000478-198210000-00003","article-title":"Primary thymic carcinomas","volume":"6","author":"Wick","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00000478-199002000-00007","article-title":"Thymic carcinoma: A clinicopathologic study of 13 cases","volume":"14","author":"Truong","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"R5-12-20210128","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-5223(20)31934-6","article-title":"Thymoma: clinicopathologic study","volume":"42","author":"Bertnatz","year":"1961","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R7-12-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-5223(98)70273-9","article-title":"Thymic carcinoma: current staging does not predict prognosis","volume":"115","author":"Blumberg","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R8-12-20210128","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma: a clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"key":"R9-12-20210128","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0899-7071(01)00327-8","article-title":"Imaging and neurological manifestations of an unusual thymic carcinoma","volume":"25","author":"Koenigsberg","year":"2001","journal-title":"Clin Imaging"},{"key":"R10-12-20210128","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/ejso.2001.1197","article-title":"Thymic carcinoma: a report of 13 cases","volume":"27","author":"Lucchi","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"R11-12-20210128","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02913143","article-title":"Thymic carcinoma with tumor thrombus into the superior vena cava","volume":"49","author":"Kamikubo","year":"2001","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"R12-12-20210128","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/1097-0142(19901115)66:10<2092::AID-CNCR2820661008>3.0.CO;2-1","article-title":"Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy","volume":"66","author":"Carlson","year":"1990","journal-title":"Cancer"},{"key":"R13-12-20210128","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial","volume":"91","author":"Loehrer","year":"2001","journal-title":"Cancer"},{"key":"R14-12-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jso.2930520412","article-title":"Treatment and prognosis of primary thymic carcinoma","volume":"52","author":"Yano","year":"1993","journal-title":"J Surg Oncol"},{"key":"R15-12-20210128","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00000421-200112000-00007","article-title":"Multimodal treatment of metastatic thymic carcinoma including high-dose chemotherapy with autologous stem cell transplantation: report of a case with more than 4-year disease-free survival","volume":"24","author":"Geffen","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"R16-12-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-1589-0_11","article-title":"Thymic malignancies","volume":"105","author":"Loehrer","year":"2001","journal-title":"Cancer Treat Res"},{"key":"R17-12-20210128","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/1097-0142(19930215)71:4<1219::AID-CNCR2820710408>3.0.CO;2-B","article-title":"Thymic carcinoma: a distinct clinical entity responsive to chemotherapy","volume":"71","author":"Weide","year":"1993","journal-title":"Cancer"},{"key":"R18-12-20210128","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00000478-199708000-00008","article-title":"Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity","volume":"21","author":"Dorfman","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R19-12-20210128","first-page":"269","article-title":"Clinical and pathologic predictors of survival in patients with thymic tumors","volume":"43","author":"Lequaglie","year":"2002","journal-title":"J Cardiovasc Surg Torino"},{"key":"R20-12-20210128","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198902233200803","article-title":"Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer: an Intergroup study","volume":"320","author":"Mansour","year":"1989","journal-title":"N Engl J Med"},{"key":"R21-12-20210128","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM198902233200804","article-title":"Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer","volume":"320","year":"1989","journal-title":"N Engl J Med"},{"key":"R22-12-20210128","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/oxfordjournals.annonc.a010636","article-title":"Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer","volume":"7","author":"Zambetti","year":"1996","journal-title":"Ann Oncol"},{"key":"R23-12-20210128","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1200\/JCO.1998.16.11.3486","article-title":"Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis\u2014an Intergroup Study","volume":"16","author":"Mansour","year":"1998","journal-title":"J Clin Oncol"},{"key":"R24-12-20210128","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1200\/JCO.1999.17.5.1349","article-title":"Comparative efficacy of adjuvant chemotherapy in patients With Dukes\u2019 B versus Dukes\u2019 C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies (C-01, C-02, C-03, and C-04)","volume":"17","author":"Mamounas","year":"1999","journal-title":"J Clin Oncol"},{"key":"R25-12-20210128","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.1990.03450110090034","article-title":"Adjuvant therapy for patients with colon and rectal cancer","volume":"264","year":"1990","journal-title":"JAMA"},{"key":"R26-12-20210128","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.2000.18.8.1652","article-title":"Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer","volume":"18","author":"Vokes","year":"2000","journal-title":"J Clin Oncol"},{"key":"R27-12-20210128","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0003-4975(01)03148-4","article-title":"Multimodality therapy for resectable cancer of the thoracic esophagus","volume":"73","author":"Entwistle","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"R28-12-20210128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1634\/theoncologist.5-6-471","article-title":"The initial results in muscle-invading bladder cancer of RTOG 95\u201306: phase I\/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response","volume":"5","author":"Kaufman","year":"2000","journal-title":"Oncologist"},{"key":"R29-12-20210128","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000421-200206000-00012","article-title":"Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy)","volume":"25","author":"Koizumi","year":"2002","journal-title":"Am J Clin Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.coc.0000046301.83671.09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:20:06Z","timestamp":1620937206000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-200402000-00012"}},"subtitle":["Results of a 30-Year Single-Institution Experience"],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.coc.0000046301.83671.09","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}